June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Subclinical alterations of extraocular muscles in Graves' Disease
Author Affiliations & Notes
  • Alberto Cuccu
    Ophthalmology, University of Cagliari, Cagliari, Italy
  • Ignazio Zucca
    Ophthalmology, University of Cagliari, Cagliari, Italy
  • Maria Silvana Galantuomo
    Ophthalmology, University of Cagliari, Cagliari, Italy
  • Stefano Mariotti
    Medical Science, University of Cagliari, Cagliari, Italy
  • Francesco Boi
    Medical Science, University of Cagliari, Cagliari, Italy
  • Rosanna Vacca
    Medical Science, University of Cagliari, Cagliari, Italy
  • Maurizio Fossarello
    Ophthalmology, University of Cagliari, Cagliari, Italy
  • Footnotes
    Commercial Relationships Alberto Cuccu, None; Ignazio Zucca, None; Maria Silvana Galantuomo, None; Stefano Mariotti, None; Francesco Boi, None; Rosanna Vacca, None; Maurizio Fossarello, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5901. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alberto Cuccu, Ignazio Zucca, Maria Silvana Galantuomo, Stefano Mariotti, Francesco Boi, Rosanna Vacca, Maurizio Fossarello; Subclinical alterations of extraocular muscles in Graves' Disease. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5901.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate the extraocular muscles involvement in Graves’ disease (GD) patients without signs of active Graves’ orbitopathy (GO). Patients were classified with Clinical Activity Score (CAS) proposed by EUropean Group of Graves' Orbitopathy. CAS is based on the presence of ocular symptoms: active lid swelling, eyelid erythema, definitive conjunctival redness, chemosis, caruncle or plical infiammation, spontaneous orbital pain, gaze evoked orbital pain.

Methods: Sixty-four GD patients asymptomatic for active GO ( CAS ≤ 2) and spontaneous diplopia were studied. CAS classification of patients was represented by thirty-five with CAS 0 with no symptoms of GO, twenty-four patients CAS 1 presented only one GO symptom, and five patients CAS 2 with two GO symptoms. All cases underwent eye examination: biomicroscopy, visual acuity, intraocular pressure (IOP) in primary gaze and upgaze with corneal applanation tonometry, cover test, ocular motility examination, red filter test (RF) to identify latent diplopia fundus examination. Thyroid function (serum FT3, FT4 and TSH) and thyroid autoantibodies (TPOAb, TGAb and anti-TSH receptor, TRAb) were also performed. At the time of the enrollment, 25/64 (39,1%) patients were subclinical hyperthyroid and the remaining 39/64 (60,9%) were euthyroid under anti-thyroid drug therapy or after thyroid definitive cure.

Results: Of nineteen patients that hadn’t IOP increase in upgaze or diplopia with RF, thirteen were CAS 0 and six were CAS 1. The remaining forty-five patients (70,3%) showed diplopia with RF or IOP increase in upgaze: 12/45 (26,6%) only IOP increase in upgaze, 13/45 (28,9%) only diplopia with RF, 20/45 (44,5%) patients had IOP increase in upgaze and diplopia with RF. Thirty-three patients showed diplopia with red filter test; 21/33 (63,3%) diplopia without ocular motility alterations, 17/35 were CAS 0 (48,6%), 11/24 were CAS 1 (45,8%) and 5/5 patients were in CAS 2 (100%).

Conclusions: This preliminary study shows an high prevalence of subclinical extraocular muscle alterations in GD patients asymptomatic for active GO, which resulted unrelated to thyroid function tests. The red filter test showed hidden diplopia in 51,5% (33/64). The red filter test is easy and inexpensive; we propose its use for early diagnosis of active Graves’ Orbitopathy, and earlier treatment. Other investigations are needed to confirm these results.

Keywords: 723 strabismus: diagnosis and detection • 522 eye movements  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×